Equivalency of drug and non-drug therapy for depression in heart failure

Written by | 3 Feb 2024

To treat depression in heart failure, patients can receive with similar efficacy either behavioral activation psychotherapy or antidepressant drug therapy, researchers report. The findings appeared on Jan.17, 2024 […]

Where patients live impacts whether they pick up their heart-failure medications

Written by | 20 Dec 2023

People who live in neighborhoods with higher levels of poverty and unemployment are less likely to fill their heart-failure drug prescriptions than those living in wealthier areas, a […]

Commonly prescribed hypertension drug, amlodipine, not actually dangerous

Written by | 14 Oct 2023

A new paper in the journal Function, published by Oxford Univetrsity Press, finds that a widely prescribed drug for treating hypertension, amlodipine, is not dangerous for patients, despite recent concerns from […]

A holistic approach to drug therapy for heart failure

Written by | 8 Jul 2023

A recent publication described the holistic approach to drug therapy in a patient with heart failure – an area where treatment has changed considerably over the past 30 […]

Who should oversee heart failure management?

Written by | 7 Jul 2023

The management of heart failure treatment is probably best done by a primary care team and pharmacists can play a major role in prescribing, says Paul Forsyth, Lead […]

What are the key challenges in the treatment of heart failure?

Written by | 6 Jul 2023

The key challenges in heart failure treatment include reaching the target dose, awareness of drug-specific issues that influence effectiveness and tackling adherence problems, according to Paul Forsyth, Lead […]

How should the four pillars of therapy for heart failure be prescribed?

Written by | 5 Jul 2023

Current thinking advocates the use of ‘four pillars of heart failure therapy’. Paul Forsyth, Lead Pharmacist, Clinical Cardiology at NHS Greater Glasgow and Clyde, explains how this treatment […]

Why does heart failure matter?

Written by | 4 Jul 2023

A recent publication described the holistic approach to drug therapy in a patient with heart failure – an area where treatment has changed considerably over the past 30 […]

Prescribing of key heart failure medications improved with tailored digital alerts

Written by | 21 Jun 2023

Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5 times as likely to prescribe mineralocorticoid receptor antagonists (MRAs), a guideline-recommended class of heart […]

NICE Quality Standards for managing chronic heart failure

Written by | 10 Mar 2023

Dr Rani Khatib is a Consultant Cardiology Pharmacist at Leeds Teaching Hospitals NHS Trust and Associate Professor at the Leeds Institute for Cardiometabolic Medicine (LICaM), University of Leeds. As […]

What are the implications of the NICE Quality Standards?

Written by | 9 Mar 2023

The updated and expanded NICE quality standards should be used in all care settings to audit and improve services for people with chronic heart failure, according to Dr […]

Why do we need NICE Quality Standards for chronic heart failure?

Written by | 8 Mar 2023

Dr Rani Khatib is a consultant pharmacist in cardiology and cardiovascular research and associate professor at the University of Leeds. As a member of the NICE Guideline Development […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.